Insulin Therapy Center

Learn why MiniMed Flex insulin pumps were recalled, the potential insulin delivery risks, and what affected users should do to stay safe.

Discover why parenteral nutrition complicates insulin dosing and how CGM-guided adjustments improved glucose control in a small clinical study.

A head-to-head trial compared a smart insulin pen vs AID in adults with type 1 diabetes. See who benefited most and why patient preference still matters.

The Pivot Insulin Delivery System received a new FDA clearance in September 2026. Learn what changed and what clinicians should know.

Discover how exercise timing in type 1 diabetes, meal timing, insulin on board, and workout intensity can influence glucose responses.

Time-restricted eating has become a popular approach to weight management, but what happens when insulin-dependent diabetes enters the picture? Until recently, evidence on time-restricted eating in people with type 1 diabetes was notably limited. A new randomized controlled trial published in Diabetes Care offers some of the first direct evidence. …

The choice of human vs analogue insulin is especially important for people with Type 1 diabetes who live where healthcare resources are limited. Analogue insulins are often preferred because their action can be more predictable and flexible. However, human insulin is generally less expensive and may be easier for health …

For millions of people who use injectable diabetes medications, treatment can mean living with needles every day. What if a small skin patch could eventually deliver insulin or other therapies with far less discomfort? Researchers studying microneedle patches for diabetes hope to make that possibility practical. These experimental patches use …

Artificial intelligence is entering diabetes care in a surprisingly quiet way. Rather than appearing as a chatbot or separate decision-support tool, increasingly sophisticated algorithms are being built into automated insulin delivery systems. Adaptive insulin pump hardware can work with continuous glucose monitor (CGM) data, recent insulin delivery, and changing glucose …

For more than a century, insulin has saved millions of lives. Yet despite remarkable advances in diabetes technology, one major challenge remains: preventing hypoglycemia while maintaining excellent glucose control. That is why researchers are developing glucose-responsive insulin, often called “smart” insulin. Instead of delivering a fixed amount of insulin regardless …